These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34255778)

  • 21. Hepatic R2* is more strongly associated with proton density fat fraction than histologic liver iron scores in patients with nonalcoholic fatty liver disease.
    Bashir MR; Wolfson T; Gamst AC; Fowler KJ; Ohliger M; Shah SN; Alazraki A; Trout AT; Behling C; Allende DS; Loomba R; Sanyal A; Schwimmer J; Lavine JE; Shen W; Tonascia J; Van Natta ML; Mamidipalli A; Hooker J; Kowdley KV; Middleton MS; Sirlin CB;
    J Magn Reson Imaging; 2019 May; 49(5):1456-1466. PubMed ID: 30318834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The relationship between myocardial and hepatic T2 and T2* at 1.5T and 3T MRI in normal and iron-overloaded patients.
    Kritsaneepaiboon S; Ina N; Chotsampancharoen T; Roymanee S; Cheewatanakornkul S
    Acta Radiol; 2018 Mar; 59(3):355-362. PubMed ID: 28592152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Volumetric Liver Fat Fraction Determines Grade of Steatosis More Accurately Than Controlled Attenuation Parameter in Patients With Nonalcoholic Fatty Liver Disease.
    Harry S; Lai LL; Nik Mustapha NR; Abdul Aziz YF; Vijayananthan A; Rahmat K; Mahadeva S; Chan WK
    Clin Gastroenterol Hepatol; 2020 Apr; 18(4):945-953.e2. PubMed ID: 31442603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deep learning reconstruction for the evaluation of neuroforaminal stenosis using 1.5T cervical spine MRI: comparison with 3T MRI without deep learning reconstruction.
    Yasaka K; Tanishima T; Ohtake Y; Tajima T; Akai H; Ohtomo K; Abe O; Kiryu S
    Neuroradiology; 2022 Oct; 64(10):2077-2083. PubMed ID: 35918450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validation of water-fat MRI and proton MRS in assessment of hepatic fat and the heterogeneous distribution of hepatic fat and iron in subjects with non-alcoholic fatty liver disease.
    Hui SCN; So HK; Chan DFY; Wong SKH; Yeung DKW; Ng EKW; Chu WCW
    Eur J Radiol; 2018 Oct; 107():7-13. PubMed ID: 30292275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of chemical shift-encoded water-fat MRI and MR spectroscopy in quantification of marrow fat in postmenopausal females.
    Li G; Xu Z; Gu H; Li X; Yuan W; Chang S; Fan J; Calimente H; Hu J
    J Magn Reson Imaging; 2017 Jan; 45(1):66-73. PubMed ID: 27341545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natively fat-suppressed 5D whole-heart MRI with a radial free-running fast-interrupted steady-state (FISS) sequence at 1.5T and 3T.
    Bastiaansen JAM; Piccini D; Di Sopra L; Roy CW; Heerfordt J; Edelman RR; Koktzoglou I; Yerly J; Stuber M
    Magn Reson Med; 2020 Jan; 83(1):45-55. PubMed ID: 31452244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Whole Brain Volume Measured from 1.5T versus 3T MRI in Healthy Subjects and Patients with Multiple Sclerosis.
    Chu R; Tauhid S; Glanz BI; Healy BC; Kim G; Oommen VV; Khalid F; Neema M; Bakshi R
    J Neuroimaging; 2016; 26(1):62-7. PubMed ID: 26118637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative MRCP Imaging: Accuracy, Repeatability, Reproducibility, and Cohort-Derived Normative Ranges.
    Goldfinger MH; Ridgway GR; Ferreira C; Langford CR; Cheng L; Kazimianec A; Borghetto A; Wright TG; Woodward G; Hassanali N; Nicholls RC; Simpson H; Waddell T; Vikal S; Mavar M; Rymell S; Wigley I; Jacobs J; Kelly M; Banerjee R; Brady JM
    J Magn Reson Imaging; 2020 Sep; 52(3):807-820. PubMed ID: 32147892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T1 at 1.5T and 3T compared with conventional T2* at 1.5T for cardiac siderosis.
    Alam MH; Auger D; Smith GC; He T; Vassiliou V; Baksi AJ; Wage R; Drivas P; Feng Y; Firmin DN; Pennell DJ
    J Cardiovasc Magn Reson; 2015 Nov; 17():102. PubMed ID: 26602203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multisite multivendor validation of a quantitative MRI and CT compatible fat phantom.
    Zhao R; Hernando D; Harris DT; Hinshaw LA; Li K; Ananthakrishnan L; Bashir MR; Duan X; Ghasabeh MA; Kamel IR; Lowry C; Mahesh M; Marin D; Miller J; Pickhardt PJ; Shaffer J; Yokoo T; Brittain JH; Reeder SB
    Med Phys; 2021 Aug; 48(8):4375-4386. PubMed ID: 34105167
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Dekkers IA; de Heer P; Bizino MB; de Vries APJ; Lamb HJ
    J Magn Reson Imaging; 2018 Aug; 48(2):507-513. PubMed ID: 29517830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apparent diffusion coefficient normalization of normal liver: Will it improve the reproducibility of diffusion-weighted imaging at different MR scanners as a new biomarker?
    Zhu J; Zhang J; Gao JY; Li JN; Yang DW; Chen M; Zhou C; Yang ZH
    Medicine (Baltimore); 2017 Jan; 96(3):e5910. PubMed ID: 28099354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interexamination repeatability and spatial heterogeneity of liver iron and fat quantification using MRI-based multistep adaptive fitting algorithm.
    Sofue K; Mileto A; Dale BM; Zhong X; Bashir MR
    J Magn Reson Imaging; 2015 Nov; 42(5):1281-90. PubMed ID: 25920074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myocardial T2* Imaging at 3T and 1.5T: A Pilot Study with Phantom and Normal Myocardium.
    Chang S; Park J; Yang YJ; Beck KS; Kim PK; Choi BW; Jung JI
    J Cardiovasc Dev Dis; 2022 Aug; 9(8):. PubMed ID: 36005435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of
    Stewart NJ; Chan HF; Hughes PJC; Horn FC; Norquay G; Rao M; Yates DP; Ireland RH; Hatton MQ; Tahir BA; Ford P; Swift AJ; Lawson R; Marshall H; Collier GJ; Wild JM
    J Magn Reson Imaging; 2018 Mar; 48(3):632-42. PubMed ID: 29504181
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Test-retest repeatability and reproducibility of ADC measures by breast DWI: Results from the ACRIN 6698 trial.
    Newitt DC; Zhang Z; Gibbs JE; Partridge SC; Chenevert TL; Rosen MA; Bolan PJ; Marques HS; Aliu S; Li W; Cimino L; Joe BN; Umphrey H; Ojeda-Fournier H; Dogan B; Oh K; Abe H; Drukteinis J; Esserman LJ; Hylton NM;
    J Magn Reson Imaging; 2019 Jun; 49(6):1617-1628. PubMed ID: 30350329
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatic steatosis modeling and MRI signal simulations for comparison of single- and dual-R2* models and estimation of fat fraction at 1.5T and 3T.
    Shrestha U; Esparza JP; Satapathy SK; Vanatta JM; Abramson ZR; Tipirneni-Sajja A
    Comput Biol Med; 2024 May; 174():108448. PubMed ID: 38626508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MRI-determined liver proton density fat fraction, with MRS validation: Comparison of regions of interest sampling methods in patients with type 2 diabetes.
    Vu KN; Gilbert G; Chalut M; Chagnon M; Chartrand G; Tang A
    J Magn Reson Imaging; 2016 May; 43(5):1090-9. PubMed ID: 26536609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Target definition for malignant gliomas: no difference in radiation treatment volumes between 1.5T and 3T magnetic resonance imaging.
    Guarnaschelli JN; Vagal AS; McKenzie JT; McPherson CM; Warnick RE; Batra V; Breneman JC; Lamba MA
    Pract Radiat Oncol; 2014; 4(5):e195-e201. PubMed ID: 25194105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.